Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

V Khoo

Showing results (51-60 of 57) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 57 results.
Clinical Oncology (Royal College of Radiologists (Great Britain))|July 25, 2013
Clinical implementation of adaptive hypofractionated bladder radiotherapy for improvement in normal tissue irradiationF McDonald, S Lalondrelle, H Taylor, et al.
Gene Therapy|January 28, 2016
Oncolytic vaccinia virus as a vector for therapeutic sodium iodide symporter gene therapy in prostate cancerD C Mansfield, J N Kyula, N Rosenfelder, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|February 23, 2010
Intensity-modulated radiotherapy allows escalation of the radiation dose to the pelvic lymph nodes in patients with locally advanced prostate cancer: preliminary results of a phase I dose escalation studyT Guerrero Urbano, V Khoo, J Staffurth, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|April 1, 1996
Radiotherapy for early infradiaphragmatic Hodgkin's disease: the Australasian experienceM Barton, J Boyages, E Crennan, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|October 17, 2017
UK Consensus on Normal Tissue Dose Constraints for Stereotactic RadiotherapyG G Hanna, L Murray, R Patel, et al.
BJU International|September 16, 2010
Targeted prostate cancer screening in men with mutations in BRCA1 and BRCA2 detects aggressive prostate cancer: preliminary analysis of the results of the IMPACT studyAnita V Mitra, Elizabeth K Bancroft, Yolanda Barbachano, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 20, 2019
EAU-ESMO consensus statements on the management of advanced and variant bladder cancer-an international collaborative multi-stakeholder effort: under the auspices of the EAU and ESMO Guidelines Committees†A Horwich, M Babjuk, J Bellmunt, et al.
Pageof 6

Showing results (51-60 of 57) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 57 results.
Clinical Oncology (Royal College of Radiologists (Great Britain))|July 25, 2013
Clinical implementation of adaptive hypofractionated bladder radiotherapy for improvement in normal tissue irradiationF McDonald, S Lalondrelle, H Taylor, et al.
Gene Therapy|January 28, 2016
Oncolytic vaccinia virus as a vector for therapeutic sodium iodide symporter gene therapy in prostate cancerD C Mansfield, J N Kyula, N Rosenfelder, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|February 23, 2010
Intensity-modulated radiotherapy allows escalation of the radiation dose to the pelvic lymph nodes in patients with locally advanced prostate cancer: preliminary results of a phase I dose escalation studyT Guerrero Urbano, V Khoo, J Staffurth, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|April 1, 1996
Radiotherapy for early infradiaphragmatic Hodgkin's disease: the Australasian experienceM Barton, J Boyages, E Crennan, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|October 17, 2017
UK Consensus on Normal Tissue Dose Constraints for Stereotactic RadiotherapyG G Hanna, L Murray, R Patel, et al.
BJU International|September 16, 2010
Targeted prostate cancer screening in men with mutations in BRCA1 and BRCA2 detects aggressive prostate cancer: preliminary analysis of the results of the IMPACT studyAnita V Mitra, Elizabeth K Bancroft, Yolanda Barbachano, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 20, 2019
EAU-ESMO consensus statements on the management of advanced and variant bladder cancer-an international collaborative multi-stakeholder effort: under the auspices of the EAU and ESMO Guidelines Committees†A Horwich, M Babjuk, J Bellmunt, et al.
Pageof 6